268 related articles for article (PubMed ID: 23950183)
1. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
Gladue H; Steen V; Allanore Y; Saggar R; Saggar R; Maranian P; Berrocal VJ; Avouac J; Meune C; Trivedi M; Khanna D
J Rheumatol; 2013 Oct; 40(10):1706-11. PubMed ID: 23950183
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population.
Hinchcliff M; Fischer A; Schiopu E; Steen VD;
J Rheumatol; 2011 Oct; 38(10):2172-9. PubMed ID: 21844142
[TBL] [Abstract][Full Text] [Related]
3. The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.
Thakkar V; Stevens W; Prior D; Youssef P; Liew D; Gabbay E; Roddy J; Walker JG; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
Arthritis Res Ther; 2013; 15(6):R193. PubMed ID: 24246100
[TBL] [Abstract][Full Text] [Related]
4. Evaluating factors influencing screening for pulmonary hypertension in systemic sclerosis: does disparity between available guidelines influence clinical practice?
Pauling JD; McHugh NJ
Clin Rheumatol; 2012 Feb; 31(2):357-61. PubMed ID: 21912881
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic.
Jansa P; Becvar R; Ambroz D; Palecek T; Tomcik M; Skacelova S; Aschermann M; Linhart A
Clin Rheumatol; 2012 Mar; 31(3):557-61. PubMed ID: 22105781
[TBL] [Abstract][Full Text] [Related]
7. Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis.
Quinlivan A; Thakkar V; Stevens W; Morrisroe K; Prior D; Rabusa C; Youssef P; Gabbay E; Roddy J; Walker JG; Zochling J; Sahhar J; Nash P; Lester S; Rischmueller M; Proudman SM; Nikpour M
Intern Med J; 2015 Nov; 45(11):1134-40. PubMed ID: 26337683
[TBL] [Abstract][Full Text] [Related]
8. Relation of novel echocardiographic measures to invasive hemodynamic assessment in scleroderma-associated pulmonary arterial hypertension.
Gopal DM; Doldt B; Finch K; Simms RW; Farber HW; Gokce N
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1386-94. PubMed ID: 24515598
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
[TBL] [Abstract][Full Text] [Related]
10. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
[TBL] [Abstract][Full Text] [Related]
11. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis.
Dumitrescu D; Nagel C; Kovacs G; Bollmann T; Halank M; Winkler J; Hellmich M; Grünig E; Olschewski H; Ewert R; Rosenkranz S
Heart; 2017 May; 103(10):774-782. PubMed ID: 28062514
[TBL] [Abstract][Full Text] [Related]
13. Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry.
Bae S; Saggar R; Bolster MB; Chung L; Csuka ME; Derk C; Domsic R; Fischer A; Frech T; Goldberg A; Hinchcliff M; Hsu V; Hummers L; Schiopu E; Mayes MD; McLaughlin V; Molitor J; Naz N; Furst DE; Maranian P; Steen V; Khanna D
Ann Rheum Dis; 2012 Aug; 71(8):1335-42. PubMed ID: 22307943
[TBL] [Abstract][Full Text] [Related]
14. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
[TBL] [Abstract][Full Text] [Related]
15. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
[TBL] [Abstract][Full Text] [Related]
16. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
Hsu VM; Moreyra AE; Wilson AC; Shinnar M; Shindler DM; Wilson JE; Desai A; Seibold JR
J Rheumatol; 2008 Mar; 35(3):458-65. PubMed ID: 18203320
[TBL] [Abstract][Full Text] [Related]
17. Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study.
Hsu VM; Chung L; Hummers LK; Wigley F; Simms R; Bolster M; Silver R; Fischer A; Hinchcliff ME; Varga J; Goldberg AZ; Derk CT; Schiopu E; Khanna D; Shapiro LS; Domsic RT; Medsger T; Mayes MD; Furst D; Csuka ME; Molitor JA; Alkassab F; Steen VD
Semin Arthritis Rheum; 2014 Aug; 44(1):55-62. PubMed ID: 24709277
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
[TBL] [Abstract][Full Text] [Related]
19. Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review.
Gladue H; Altorok N; Townsend W; McLaughlin V; Khanna D
Semin Arthritis Rheum; 2014 Feb; 43(4):536-41. PubMed ID: 24012044
[TBL] [Abstract][Full Text] [Related]
20. Echocardiographic assessment of regional right ventricular systolic function using two-dimensional strain echocardiography and evaluation of the predictive ability of longitudinal 2D-strain imaging for pulmonary arterial hypertension in systemic sclerosis patients.
Hekimsoy V; Kaya EB; Akdogan A; Sahiner L; Evranos B; Canpolat U; Aytemir K; Özer N; Tokgozoglu L
Int J Cardiovasc Imaging; 2018 Jun; 34(6):883-892. PubMed ID: 29322374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]